Central Neurocytoma

Common Name(s)

Central Neurocytoma

A central neurocytoma (CNC) is a rare brain tumor usually found in people between the ages of 20-40 years old. The tumors are most often benign (non-cancerous). Typical symptoms of this condition may include headaches, increased pressure in the skull, blurred vision, nausea, vomiting, drowsiness and seizures.

Generally, CNC tumors can be completely removed by surgery, but depending on certain qualities of the tumor, such as size and rate of tumor growth, removal of the tumor may need to be followed with radiation therapy. Chemotherapy may be suggested if the tumor returns (recurs). The majority of patients with CNC are cured by the removal of the tumor and become long-term survivors (living tumor free for over 10 years). However, as with any other type of tumor, there is a chance for recurrence or the CNC returning. If you or a member of your family has been diagnosed with a central neurocytoma, talk to your doctor about the most current treatment options. Support groups are also a good source of support and information.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Central Neurocytoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Central Neurocytoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Central Neurocytoma" returned 33 free, full-text research articles on human participants. First 3 results:

Role of adjuvant radiation in the management of central neurocytoma: Experience from a tertiary cancer care center of India.
 

Author(s): S Mallick, S Roy, S Das, N P Joshi, V Roshan, A K Gandhi, M Jana, P K Julka, G K Rath

Journal: Indian J Cancer. ;52(4):590-7.

 

Neurocytoma (NC) is a rare benign neuronal tumor. A complete excision remains curative for most of these tumors, but atypical histology and extra-ventricular location often necessitates adjuvant therapy. We intended to explore the clinico-pathological features and treatment outcome ...

Last Updated: 31 Dec 1969

Go To URL
Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience.
 

Author(s): Brandon S Imber, Steve E Braunstein, Fred Y Wu, Nima Nabavizadeh, Nicholas Boehling, Vivian K Weinberg, Tarik Tihan, Michael Barnes, Sabine Mueller, Nicholas A Butowski, Jennifer L Clarke, Susan M Chang, Michael M McDermott, Michael D Prados, Mitchel S Berger, Daphne A Haas-Kogan

Journal: J. Neurooncol.. 2016 Jan;126(1):193-200.

 

Central neurocytomas are uncommon intraventricular neoplasms whose optimal management remains controversial due to their rarity. We assessed outcomes for a historical cohort of neurocytoma patients and evaluated effects of tumor atypia, size, resection extent, and adjuvant radiotherapy. ...

Last Updated: 31 Dec 1969

Go To URL
Intraventricular hemorrhage--unusual presentation of central neurocytoma.
 

Author(s): Prashant V Gunawat, Subodh Shantaram Patil, Vikram S Karmarkar, Chandrashekhar E Deopujari

Journal: Neurol India. ;62(6):691-3.

 

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Central Neurocytoma" returned 4 free, full-text review articles on human participants. First 3 results:

[Treatment of central neurocytoma. Experience at a single institution].
 

Author(s): A Rodríguez De Lope, A De La Lama, N López-Ariztegui, R Martínez, C Conde, C Fiaño, F Vázquez

Journal: Neurocirugia (Astur). 2004 Apr;15(2):128-36; discussion 136-7.

 

Central neurocytomas are classically considered as a rare, intraventricular benign tumours with neuronal differentiation derived from precursor cells of subventricular matrix. However some patients with neoplasms with histologic atypia and elevated proliferation potential may have ...

Last Updated: 31 Dec 1969

Go To URL
Radiation therapy of well-differentiated neuroblastoma and central neurocytoma.
 

Author(s): K Nakagawa, Y Aoki, K Sakata, Y Sasaki, M Matsutani, A Akanuma

Journal: Cancer. 1993 Aug;72(4):1350-5.

 

Central neurocytoma is a rare intraventricular tumor with prominent neuronal differentiation. Although reported cases of this disease are increasing, the clinical benefit of radiation therapy remains unclear.

Last Updated: 31 Dec 1969

Go To URL
Central neurocytoma--case report.
 

Author(s): T Tamiya, T Furuta, S Asari, A Nishimoto

Journal: Neurol. Med. Chir. (Tokyo). 1990 Mar;30(3):178-83.

 

The authors present a case of central neurocytoma in a 34-year-old female who had experienced intermittent headaches over a 10-year period. On computed tomographic (CT) scans and magnetic resonance images, the tumor appeared as a large, calcified mass occupying both lateral ventricles. ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.